Dyfyniad APA

Hagiwara, A., Tanaka, N., Uemura, T., Matsuda, W., & Kimura, A. (2016). Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: A single-centre, open-label, randomised controlled trial. BMJ Open.

Dyfyniad Arddull Chicago

Hagiwara, Akiyoshi, Noriko Tanaka, Tatsuki Uemura, Wataru Matsuda, and Akio Kimura. "Can Recombinant Human Thrombomodulin Increase Survival Among Patients With Severe Septic-induced Disseminated Intravascular Coagulation: A Single-centre, Open-label, Randomised Controlled Trial." BMJ Open 2016.

Dyfyniad MLA

Hagiwara, Akiyoshi, et al. "Can Recombinant Human Thrombomodulin Increase Survival Among Patients With Severe Septic-induced Disseminated Intravascular Coagulation: A Single-centre, Open-label, Randomised Controlled Trial." BMJ Open 2016.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.